Form 4: Incyte Director Julian C. Baker Receives Equity Compensation Grant

Incyte Corporation's director, Julian C. Baker, was granted 2,518 restricted stock units and 9,216 non-qualified stock options as part of his compensation, as detailed in a recent SEC Form 4 filing.

Summary

• Julian C. Baker, a director of Incyte Corporation and managing member of Baker Bros. Advisors (GP) LLC, received a grant of equity compensation on June 10, 2025.
• The compensation includes 2,518 restricted stock units (RSUs) and 9,216 non-qualified stock options.
• The RSUs and stock options were granted under Incyte's Amended and Restated 2010 Stock Incentive Plan.
• The RSUs and stock options will vest on the earlier of June 10, 2026, the date of the next annual meeting of stockholders, or upon a change in control, subject to Julian C. Baker's continuous service on the board.
• The stock options have a strike price of $70.07 and expire on June 9, 2035.
• Baker Bros. Advisors LP, 667, L.P., Baker Bros. Advisors (GP) LLC, Baker Brothers Life Sciences LP, Felix J. Baker, and Julian C. Baker are listed as reporting persons, indicating their indirect beneficial ownership through various funds and entities.
• Julian C. Baker and Felix J. Baker disclaim beneficial ownership of securities held by the Funds and FBB Associates except to the extent of their pecuniary interest.
• The filing also notes Julian C. Baker's direct ownership of 278,773 shares of Common Stock and Felix J. Baker's direct ownership of 281,190 shares of Common Stock.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of director compensation, which is an expected part of corporate governance and does not inherently indicate a positive or negative shift in company performance or outlook.

Positives

• The grant of restricted stock units and stock options to a director aligns management's interests with those of shareholders, as the value of this compensation is tied to the company's stock performance.
• The compensation is part of a pre-existing incentive plan, indicating a structured approach to executive and director remuneration.

Corporate Governance

Related Party Transactions

• Julian C. Baker, a director of Incyte Corporation, received equity compensation (RSUs and stock options) from the Issuer.
• Baker Bros. Advisors LP and its related entities (667, L.P., Baker Bros. Advisors (GP) LLC, Baker Brothers Life Sciences LP, Felix J. Baker, and Julian C. Baker) are deemed to have indirect beneficial ownership of these securities due to their relationship with Julian C. Baker and their investment advisory roles for the Funds.

Stakeholder Impact

• Shareholders: The grant of new equity awards could lead to minor dilution, but it also serves to align the interests of a key director with shareholder value creation.
• Management/Directors: Julian C. Baker's compensation package is enhanced, providing further incentive for his continued service and performance on the board.

Next Steps

• Vesting of the 2,518 Restricted Stock Units (RSUs) on the earlier of June 10, 2026, the date of the next annual meeting of stockholders, or upon a change in control.
• Vesting of the 9,216 Non-Qualified Stock Options on the earlier of June 10, 2026, the date of the next annual meeting of stockholders, or upon a change in control.
• Potential exercise of the Non-Qualified Stock Options by June 9, 2035, if the stock price is favorable.

Key Dates

Keywords

Incyte Corp, INCY, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Stock Options, Equity Compensation, Director Compensation, Baker Bros. Advisors, Julian C. Baker, Beneficial Ownership